Old Web
English
Sign In
Acemap
>
authorDetail
>
Johnson Yn Lau
Johnson Yn Lau
Hong Kong Polytechnic University
Hepatitis B virus
Pharmacology
Medicine
Biology
Viral hepatitis
3
Papers
96
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety, Tolerability, and Pharmacokinetics of ARC‐520 Injection, an RNA Interference‐Based Therapeutic for the Treatment of Chronic Hepatitis B Virus Infection, in Healthy Volunteers
2017
Clinical pharmacology in drug development
T. Schluep
Jason D. Lickliter
J Hamilton
David L. Lewis
Ching-Lung Lai
Johnson Yn Lau
Stephen Locarnini
Robert G. Gish
B. Given
Show All
Source
Cite
Save
Citations (53)
Inhibition of Hec1 as a novel approach for treatment of primary liver cancer
2014
Cancer Chemotherapy and Pharmacology
Lynn Yl Huang
Chia-Chi Chang
Ying-Shuan Lee
Jiann-Jyh Huang
Shih-Hsien Chuang
Jia-Ming Chang
Kuo-Jang Kao
Gillian M. Lau
Pei-Yi Tsai
Chia-Wei Liu
Her-Sheng Lin
Robert G. Gish
Johnson Yn Lau
Show All
Source
Cite
Save
Citations (14)
The variability of the hepatitis B virus genome: statistical analysis and biological implications.
1993
Molecular Biology and Evolution
Ian J. Lauder
Hsiang-Ju Lin
Johnson Yn Lau
Tak-shing. Siu
Ching-Lung Lai
Show All
Source
Cite
Save
Citations (29)
1